Leonard B Bacharier

Washington University

$9,616,060

Attributed

$18,078,517

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY2005–25

$5M$3.8M$2.5M$1.3M$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

'24

'25

Funding mix

By agency

NIH$18,078,517 · 9

By mechanism

R01$6,278,960 · 3

U10$4,518,096 · 1

UG3$3,488,939 · 1

U01$2,036,652 · 1

UH3$1,172,231 · 1

T32$430,606 · 1

Top collaborators

Most similar at Washington University

Same institution · by research overlap

Mario Castro$45,956,792
Robert C Strunk$18,363,723
Michael Jay Holtzman$55,932,256
Neil H. White$12,778,445
Anand Champak Patel$600,467

Others in their field

Top investigators on “Asthma”

James E. Gern · University Of Wisconsin-Madison$159,588,264
William W. Busse · University Of Wisconsin Madison$104,093,792
Scott T Weiss · University Of California, San Diego$98,211,117
David T Mauger · Pennsylvania State Univ Hershey Med Ctr$79,309,576
Fernando D Martinez · University Of Arizona$66,357,737
Wanda Phipatanakul · Boston Children'S Hospital$50,505,446

Research focus

AsthmaChildDiagnosisMorbidity - Disease RateChildhoodCohortHypersensitivityClinical TrialsLifeChildhood AsthmaPhenotypeBronchiolitisClinical ResearchAllergicInfantLeadCaringProgramsProspectiveSeveritiesAcuteCharacteristicsPediatric HospitalsVisit

Grant awards (26)

ECHO Renewal for the INSPIRE Study Cohort$1,172,231

UH3 · FY2025 · OD

Vanderbilt University Medical Center (VUMC) CoFAR Clinical Research Center$1,008,296

U01 · FY2025 · AI · contact PI

Pediatric Cardiorespiratory Research Training Program: Childhood origins of diseases across the lifespan.$430,606

T32 · FY2025 · HL · contact PI

ECHO Renewal for the INSPIRE Study Cohort$1,663,001

UG3 · FY2024 · OD

Vanderbilt University Medical Center (VUMC) CoFAR Clinical Research Center$678,356

U01 · FY2024 · AI · contact PI

Vanderbilt University Medical Center (VUMC) CoFAR Clinical Research Center$350,000

U01 · FY2024 · AI · contact PI

ECHO Renewal for the INSPIRE Study Cohort$1,825,938

UG3 · FY2023 · OD

AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$673,248

R01 · FY2020 · HL

AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$697,570

R01 · FY2019 · HL

AZITHROMYCIN TO PREVENT RECURRENT WHEEZING FOLLOWING SEVERE RSV BRONCHIOLITIS$733,063

R01 · FY2018 · HL

Randomized Controlled Trial: VDAART Continuation Study - CCC$364,437

R01 · FY2018 · HL · contact PI

Randomized Controlled Trial: VDAART Continuation Study - CCC$418,523

R01 · FY2017 · HL · contact PI

Randomized Controlled Trial: VDAART Continuation Study - CCC$442,026

R01 · FY2016 · HL · contact PI

Washington University AsthmaNet$322,367

U10 · FY2015 · HL

Washington University AsthmaNet$482,298

U10 · FY2014 · HL

Washington University AsthmaNet$799,546

U10 · FY2013 · HL

Washington University AsthmaNet$801,789

U10 · FY2012 · HL

Determinants of Asthma Following RSV Bronchiolitis in Early Life$722,078

R01 · FY2012 · HL

Washington University AsthmaNet$803,678

U10 · FY2011 · HL

Determinants of Asthma Following RSV Bronchiolitis in Early Life$742,595

R01 · FY2011 · HL

Washington University AsthmaNet$805,134

U10 · FY2010 · HL

Determinants of Asthma Following RSV Bronchiolitis in Early Life$751,735

R01 · FY2010 · HL

Determinants of Asthma Following RSV Bronchiolitis in Early Life$733,685

R01 · FY2009 · HL

Washington University AsthmaNet$503,284